diet, a benzothiadiazine, a mercurial, or an aldosterone antagonist.'-6 These measures have in common the induction of a sodium deficit. In the nonedematous hypertensive patient, 1 or 2 liters of extracellular fluid are lost, and plasma volume is reduced.2' Following the diuresis the pressor response to norepinephrine is decreased and the depressor response to ganglion-blocking agents increased. [7] [8] [9] [10] [11] [12] The hemodynamic effects of the induced oligemia have been considered by some investigators to account wholly or in large part for the antihypertensive effects of salt depletion.2' 10,13 However, several observations oppose this concept. Plasma volume and cardiac output are reduced in the first week of administration of a benzothiadiazine,13-15 but within a month the plasma volume deficit becomes small and cardiac output is no longer decreased.16 Within 6 months plasma volume may return to pretreatment levels, although the antihypertensive effects persist.17 Re-expansion of plasma volume by intravenous administration of Dextran or plasma returned the basal blood pressure and the response to a ganglion-blocking agent to control levels in some studies,2' 4, 9 but not in others.5 6, 12 This report summarizes studies designed to elucidate the mechanisms by which the basal Supported by grants no. H-1835 and H-6119 from the National Heart Institute, U. S. Public Health Service, and by grant no. 446 from the Massachusetts Heart Asso'iation. 788 blood pressure and the blood pressure responses to pressor and depressor substances are affected by a benzothiadiazine.
Materials and Methods Nine of the 10 patients studied had essential hypertension. The tenth patient (H.F.) had chronic glomerulonephritis. All had grade two fundi (Keith-Wagener scale). None showed evidence of congestive heart failure. Dietary sodium was not restricted.
The basal blood pressure, the pressor response to norepinephrine, and the depressor responses to trimethapan, erythrol tetranitrate, and protoveratrine B were determined in four periods of study. In the first period a placebo was administered for at least 4 weeks. Hydrochlorothiazide was given as the sole long-term antihypertensive measure in daily doses of 150 mg. in the subsequent periods of study. The basal blood pressure and the responses to the vasoactive substances were re-examined after 2 weeks of hydrochlorothiazide therapy. The effects of re-expansion of plasma volume by Dextran were then studied. Five hundred milliliters of 6 per cent Dextran in 5 per cent glucose in water were infused intravenously at a rate of approximately 20 ml. per minute. Ninety minutes later the blood pressure and responses to vasoactive drugs were determined. Upon completion of these studies 20 Gm. of sodium chloride were added daily for a week, at which time the responses were again examined.
The following procedures were carried out in each period of study. All During continued administration of hydrochlorothiazide, the response to norepinephrine was reexamined after return of blood pressure by an infusion of angiotensin II to the original levels observed prior to hydrochlorothiazide therapy. Ninety minutes after intravenous administration of 500 ml. of 6 per cent Dextran in 5 per cent glucose in water, angiotensin II was given intravenously at a rate determined in the individual patient to return the blood pressure approximately to the levels of the placebo period of study. During continuation of the infusion of angiotensin II norepinephrine was added intravenously for 10 minutes at a rate of 5.5 meg. per minute by a second constant infusion pump. The average blood pressure during the sixth to tenth minutes was taken to represent the response.
Results Effects of Hydrochlorothiazide
The blood pressure was significantly lower during administration of hydrochlorothiazide Figure 1 The mean values of the basal blood pressures and the blood pressure responses to norepinephrine, trimethapan, erythrol tetranmitrate, and protoveratrine B during oral administration of a placebo and during hydrochlorothiazide therapy with and without added Dextran or salt.
than during administration of a placebo (p < .001) (table 1). Systolic pressure fell an average of 13 per cent and diastolic an average of 9 per cent.
Intravenous infusion of norepinephrine at a rate of 5.5 mcg. per minute was followed by a pressor response in each case during administration of a placebo or hydrochlorothiazide. The absolute levels of blood pressure during infusions of norepinephrine were lower in the diuretic than in the placebo period of study (table 2) . However, the relative increments of response to norepinephrine, calculated in terms of per cent change in systolic and diastolic pressure, were not affected by hydroehlorothiazide (table 3) .
Continuous intravenous infusion of trimethapan lowered the blood pressure of each subject during the placebo and diuretic periods of study. Systolic and diastolic pressures during infusions of trimethapan were significantly lower during administration of hydrochlorothiazide than during the placebo period (table 4) .
Circulation, Volume XXIV, October 1961 20 Gm. returns body weight, blood pressure, and responses to vasoactive substances essentially to control levels, despite continued administration of a benzothiadiazine. Body potassium is further depleted.6 These findings oppose the concept that benzothiadiazines have a direct hypotensive action, and indicate that benzothiadiazines are antihypertensive by way of depletion of sodium and not potassium. It is difficult to relate the antihypertensive effects to a correction of excess body salt or water, since total body water, extracellular volume, plasma volume, and 24-hour exchangeable sodium are not greater in patients with uncomplicated essential hypertension than in normotensive subjects. 24 Changes in extracellular-intracellular sodium gradient can affect contractility.25 However, the losses of sodium and water associated with the administration of a thiazide were consistent with the loss of isotonic extracelluJar fluid in studies in another and in this laboratory.2 6 Others found intracellular water or sodium depleted.17 ' 26 The present studies suggest that the ability of arterioles to constrict is not impaired by hydrochlorothiazide. It had been considered that if a diuretic reduced arteriolar contractility, the per cent rise in blood pressure during an infusion of norepinephrine would be lower after administration of a diuretic than in a control period. However, the relative increments of response to norepinephrine were not decreased by hydrochlorothiazide. On the other hand, since the basal blood pressure was reduced by the diuretic, the relative increments of response to norepinephrine from this lower level of blood pressure might have been greater if arteriolar contractility had not been impaired. To circumvent the differences in both plasma volume and pre-infusion blood pressure, plasma volume was re-expanded by Dextran, and a continuous intravenous infusion of angiotensin II was added at a rate determined to return the blood pressure to the prediuretic levels. Under these circumstances the response to norepinephrine was similar to that before administration of the diuretic.
Hypertensive and normotensive subjects differ in response to a benzothiadiazine. ChloCirculation, Volume XXIV. October 1961 rothiazide does not reduce the basal blood pressure in normotensive subjects, although it reduces the responses to norepinephrine and increases the response to trimethapan; repletion of the plasma volume in these patients fully restores the norepinephrine and trimethapan responses to prediuretic levels.27 It appears that compensatory mechanisms normally are adequate to maintain the basal blood pressure despite a mild reduction in plasma volume, and that benzothiadiazines affect the blood pressure responses to pressor and depressor drugs in normotensive subjects only by way of hypovolemia. These observations stand in contrast to the observations in hypertensive patients.
The effects of sodium depletion on the basal blood pressure and the blood pressure responses to vasoactive substances in hypertensive patients can be explained by the hemodynamic effects of oligemia on systolic pressure and by an additional mechanism that decreases peripheral vascular resistance. Since there is indirect evidence that arteriolar contractility is not impaired, the concept is suggested that salt depletion reduces the degree of vasoconstrictor stimulation of the arteriolar bed. A decrease in extracellular volume, a local change in sodium concentration, or a secondary effect of chronic hypovolemia may interfere with a humoral or neurogenic pressor mechanism by which the hypertensive state is maintained. The amounts of angiotensin II necessary to restore the blood pressure to pretreatment levels during thiazide administration were small, averaging 0.3 meg. per minute. An investigation of the effects of sodium depletion on humoral and neurogenic vasoconstrictor activity is planned. It is concluded that the antihypertensive effects of hydrochlorothiazide are related to salt depletion, which acts by an effect of oligeinia on systolic pressure and by an additional mechanism that decreases peripheral vascular resistance. The induced oligemia plays an important role therapeutically because it exaggerates the hypotensive effects of drugs that reduce venous return or increase vascular capacity.
Two indirect studies suggest that arteriolar contractility is not impaired by the degree of salt depletion induced by hydrochlorothiazide. 1. The relative increments of response to norepinephrine were not decreased by the diuretic. 2 . After re-expansion of plasma volume by Dextran and the addition of an intravenous infusion of angiotensin II at a rate determined to return systolic and diastolic pressures to prediuretic levels during continued administration of hydrochlorothiazide, the response to norepinephrine was similar to that before the diuretic was administered.
The combined observations suggest that the antihypertensive effects of salt depletion result from the hemodynamic effects of oligemia and another action which reduces the degree of humoral or neurogenic vasoconstrictor stimulation of the arteriolar bed.
